IP Library › Granted Patent US 7,078,507
Granted Patent B2
US 7,078,507 · App. 10/293,913 · Granted Jul 18, 2006

Synthetic genes for malarial proteins and methods of use

Assignee: The United States of America as represented by the Secretary, Department of Health and Human Services
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,078,507
App. No.
10/293,913
Granted
Jul 18, 2006
Kind
B2
Abstract

Synthetic gene sequences encoding erythrocyte binding protein of a malaria pathogen for the expression of the erythrocyte binding protein. The codon composition of the synthetic gene sequences approximates the mammalian codon composition. The synthetic gene sequences are useful for incorporation into the DNA vaccine vectors, for the incorporation into various expression vectors for production of malaria proteins, or both. The synthetic genes may be modified to avoid post-translational modification of the encoded protein in hosts. Administration of the synthetic gene sequences, or the encoded protein, as an immunization agent is useful for induction of immunity against malaria, treatment of malaria, or both.

Claims (3)

1. An isolated synthetic nucleotide sequence encoding a domain of the erythrocyte-binding protein of a malaria pathogen that infects humans, wherein codon usage of the synthetic nucleotide sequence is altered compared to a naturally occurring sequence of the erythrocyte-binding protein in order to approximate codon usage of a host of the malaria pathogen, wherein the host is a human, and wherein the domain of the erythrocyte-binding protein is the region II of in 3D7 (NIH) Plasmodium falciparum EBA-175 protein.

2. The synthetic nucleotide sequence of claim 1 , wherein the codon-altered sequence is SEQ ID NO: 1.

3. The synthetic nucleotide sequence of claim 1 , wherein the codon-altered sequence encodes the amino acid sequence SEQ ID NO: 2.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 7, 2004
From: ENTREMED, INC.
To: HEALTH AND HUMAN SERVICES, DEPARTMENT OF, THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY,
Reel/Frame 014241/0309 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 10, 2003
From: NARUM, DAVID; LIANG, HONG; FURHMANN, STEVE; SIM, B. KIM LEE
To: ENTREMED, INC.
Reel/Frame 013742/0304 →
Continuity (2)
Provisional Application 6034505100 · Nov 9, 2001
Related Publication 20040022805A1 · Feb 5, 2004